Trial · NCT05417308
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of days assigned medication was taken/applied | Up to 12 months | For the oral minoxidil group, the proportion of pills taken will be reported with a 95% confidence interval. For the topical minoxidil group, the proportions of days medication was applied will be reported with a 95% confidence interval. |
| Secondary | Occurrence of at least one adverse event (AE) of grade 1 or higher | Up to 12 months | Adverse events will be summarized using National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0 with reporting of the number and percentage of patients affected. The total number of participants with AEs of any grade, and the total number of participants with grade 3 or higher AEs will be compared between randomized groups using Fisher's exact test. |
| Secondary | Change in hair density | Baseline to 3 months | At least mild-to-moderate improvement in hair density from baseline to 3 months as determined by a board-certified dermatologist from photographs. Will construct two-sided 95% confidence intervals for improvements from baseline and differences between randomized groups. Response will be dichotomized as no improvement versus moderate-to-significant improvement. |
| Secondary | Change in hair density | Baseline to 6 months | At least mild-to-moderate improvement in hair density from baseline to 6 months as determined by a board-certified dermatologist from photographs. Will construct two-sided 95% confidence intervals for improvements from baseline and differences between randomized groups. Response will be dichotomized as no improvement versus moderate-to-significant improvement. |
| Secondary | Change in hair density | Baseline to 12 months | At least mild-to-moderate improvement in hair density from baseline to 12 months as determined by a board-certified dermatologist from photographs. Will construct two-sided 95% confidence intervals for improvements from baseline and differences between randomized groups. Response will be dichotomized as no improvement versus moderate-to-significant improvement. |
| Secondary | Chemotherapy Alopecia Distress Scale (CADS) score | At 3 months | Patients will complete a a self-administered 17-item questionnaire |
| Secondary | CADS score physical | At 6 months | a self-administered 17-item questionnaire which categorizes questions into 4 subscales including physical |
| Secondary | CADS score physical | At 6 months | a self-administered 17-item questionnaire which categorizes questions into 4 subscales including physical relationship |
| Secondary | CADS score emotional | At 12 months | a self-administered 17-item questionnaire which categorizes questions into 4 subscales including emotional relationship |
| Secondary | Patient-reported outcomes | At 3 months | Mean responses to the symptom experience diary questions and the satisfaction items will be compared between groups via t-test. |
| Secondary | Patient-reported outcomes | At 6 months | Mean responses to the symptom experience diary questions and the satisfaction items will be compared between groups via t-test. |
| Secondary | Patient-reported outcomes | At 12 months | Mean responses to the symptom experience diary questions and the satisfaction items will be compared between groups via t-test. |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05417308/registered